MAPT and neurodegenerative disease: In summary, this evidence underlines the importance of the analysis by the occlusion algorithm for our further studies using early and late biomarkers in the pathological processing of Tau protein directed towards its amino-terminal and carboxyl-terminal end, respectively, which can be validated among different neurodegenerative diseases that have the common factor of pathological PTMs of the Tau polypeptide [68].